These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7948013)

  • 21. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
    Chirieac DV; Collins HL; Cianci J; Sparks JD; Sparks CE
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E42-9. PubMed ID: 14970003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production.
    Chirieac DV; Chirieac LR; Corsetti JP; Cianci J; Sparks CE; Sparks JD
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1003-11. PubMed ID: 11052954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
    Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
    Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance.
    Zammit VA; Waterman IJ; Topping D; McKay G
    J Nutr; 2001 Aug; 131(8):2074-7. PubMed ID: 11481396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production.
    Duez H; Lamarche B; Uffelman KD; Valéro R; Szeto L; Lemieux S; Cohn JS; Lewis GF
    J Clin Endocrinol Metab; 2008 May; 93(5):1722-9. PubMed ID: 18285418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of insulin in the control of hepatic fatty acid and glycerolipid metabolism assessed by studies in vivo.
    Zammit VA
    Braz J Med Biol Res; 1995 Oct; 28(10):1027-31. PubMed ID: 8634673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.
    Adiels M; Westerbacka J; Soro-Paavonen A; Häkkinen AM; Vehkavaara S; Caslake MJ; Packard C; Olofsson SO; Yki-Järvinen H; Taskinen MR; Borén J
    Diabetologia; 2007 Nov; 50(11):2356-65. PubMed ID: 17849096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of apolipoprotein secretion in very-low-density and high-density lipoproteins from cultured rat hepatocytes by dexamethasone.
    Martin-Sanz P; Vance JE; Brindley DN
    Biochem J; 1990 Nov; 271(3):575-83. PubMed ID: 2244866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid and lipoprotein dysregulation in insulin resistant states.
    Avramoglu RK; Basciano H; Adeli K
    Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential modulation of hepatic very low-density lipoprotein secretion by triacylglycerol-rich lipoproteins derived from different oleic-acid rich dietary oils.
    Perona JS; Avella M; Botham KM; Ruiz-Gutierrez V
    Br J Nutr; 2008 Jan; 99(1):29-36. PubMed ID: 17651518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptation of enterocytic Caco-2 cells to glucose modulates triacylglycerol-rich lipoprotein secretion through triacylglycerol targeting into the endoplasmic reticulum lumen.
    Pauquai T; Bouchoux J; Chateau D; Vidal R; Rousset M; Chambaz J; Demignot S
    Biochem J; 2006 Apr; 395(2):393-403. PubMed ID: 16393142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin.
    Wiegman CH; Bandsma RH; Ouwens M; van der Sluijs FH; Havinga R; Boer T; Reijngoud DJ; Romijn JA; Kuipers F
    Diabetes; 2003 May; 52(5):1081-9. PubMed ID: 12716736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance.
    Taher J; Baker CL; Cuizon C; Masoudpour H; Zhang R; Farr S; Naples M; Bourdon C; Pausova Z; Adeli K
    Mol Metab; 2014 Dec; 3(9):823-33. PubMed ID: 25506548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins.
    Yao Z; McLeod RS
    Biochim Biophys Acta; 1994 May; 1212(2):152-66. PubMed ID: 8180241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both insulin resistance and diabetes in Psammomys obesus upregulate the hepatic machinery involved in intracellular VLDL assembly.
    Zoltowska M; Ziv E; Delvin E; Lambert M; Seidman E; Levy E
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):118-23. PubMed ID: 14604833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic dyslipidaemia: from basic research to clinical practice.
    Taskinen MR
    Diabetologia; 2003 Jun; 46(6):733-49. PubMed ID: 12774165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.